Alendronate [alendronát]
topical
170
- Terms
-
alendronát sodný
Fosamax
kyselina alendronová
natrii alendronas trihydricus
trihydrát sodné soli alendronátu
-
4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
Alendronate Monosodium Salt, Trihydrate
Alendronate Sodium
Aminohydroxybutane Bisphosphonate
Fosamax
MK-217
Persistent link
https://www.medvik.cz/link/D019386
Definition
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
- DUI
- D019386 MeSH Browser
- CUI
- M0028852
- Previous indexing
- Diphosphonates (1987-1996)
- History note
- 1997 (1987)
- Public note
- 1997; ALENDRONATE was indexed under DIPHOSPHONATES 1987-1996
Allowable subheadings
- AD
- administration & dosage 76
- AE
- adverse effects 32
- AG
- agonists
- AA
- analogs & derivatives 7
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 2
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 3
- PK
- pharmacokinetics 9
- PD
- pharmacology 55
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 107
- TO
- toxicity
- UR
- urine 1
...
Occurrences in Medvik records
D
Chemicals and Drugs
Maxmarvil Chemical MeSH Browser